PSNL
PSNL
NASDAQ · Life Sciences Tools & Services

Personalis Inc

$16.40
+0.17 (+1.05%)
Financial Highlights (FY 2026)
Revenue
82.49M
Net Income
-96,254,431
Gross Margin
22.6%
Profit Margin
-116.7%
Rev Growth
+2.3%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 22.6% 22.6% 34.5% 34.5%
Operating Margin -126.4% -113.8% 8.7% 7.6%
Profit Margin -116.7% -110.9% 7.4% 5.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 82.49M 80.64M 842.44M 788.11M
Gross Profit 18.68M 18.26M 290.48M 271.75M
Operating Income -104,296,189 -91,756,178 73.02M 60.07M
Net Income -96,254,431 -84,681,317 62.65M 45.28M
Gross Margin 22.6% 22.6% 34.5% 34.5%
Operating Margin -126.4% -113.8% 8.7% 7.6%
Profit Margin -116.7% -110.9% 7.4% 5.8%
Rev Growth +2.3% +2.3% +3.3% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 17.08M 17.08M 109.54M 111.95M
Total Equity 849.60M 849.60M 454.92M 451.32M
D/E Ratio 0.02 0.02 0.24 0.25
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -92,396,644 -85,803,335 87.86M 84.18M
Free Cash Flow 62.43M 43.12M